Seven months after the Supreme Court nullified a previous settlement regarding Purdue Pharma’s opioid litigation, the Sackler family has proposed a new cash settlement worth up to $6.5 billion. Unlike their previous demands for immunity from future lawsuits, this new proposal requires claimants to reserve funds—up to $800 million—as a legal-defense account for the Sacklers. New York Attorney General Letitia James announced the overall settlement of $7.4 billion, emphasizing the family's culpability in the opioid crisis and ensuring that they will lose control over Purdue Pharma and not be permitted to sell opioids in the U.S. again.
Under the framework for a new deal, the Sacklers would not receive immunity from future opioid lawsuits, a condition that they had long insisted upon but that the court ruled was impermissible.
New York attorney general, Letitia James, indicated that the overall settlement totaled $7.4 billion, which would include up to $6.5 billion from the Sackler family.
The Sackler family relentlessly pursued profit at the expense of vulnerable patients and played a critical role in starting and fueling the opioid epidemic.
When the deal is finalized, the Sacklers will no longer have control of Purdue and will never be allowed to sell opioids in the United States again.
Collection
[
|
...
]